HRMYHarmony Biosciences Holdings, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 16625
Ticker: HRMY
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-08-19
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: HRMY

Detail

Enriched 2026-08-14 20:47

Market cap: $2,316,061,349.61
Shares outstanding (class): 58,236,393
Shares outstanding (weighted): 58,236,393
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 293
Location: PLYMOUTH MEETING, PA
Homepage: https://www.harmonybiosciences.com
Description: Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Market cap and share counts drift.

Funds holding this security

150 funds · 152 positions · $338.21M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Core S&P Small-Cap ETF iShares Trust	IJR	$66.77M	0.07%	2,383,813 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$43.97M	0.00%	1,569,802 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$31.76M	0.02%	1,133,959 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$29.94M	0.04%	1,069,026 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$17.75M	0.05%	633,792 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$12.51M	0.02%	446,791 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 600(TM) S… SPDR SERIES TRUST	SPSM	$10.17M	0.07%	363,227 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$9.98M	0.08%	356,236 NS	FIGI
iShares S&P Small-Cap 600 Growth ETF iShares Trust	IJT	$9.60M	0.15%	342,892 NS	FIGI
VANGUARD TAX-MANAGED SMALL-CAP FUND VANGUARD TAX-MANAGED FUNDS	—	$7.03M	0.07%	250,884 NS	FIGI
State Street(R) SPDR(R) S & P 600(TM) Small Cap… SPDR SERIES TRUST	SLYG	$5.87M	0.15%	209,693 NS	FIGI
State Street(R) SPDR(R) S&P(R) Pharmaceuticals … SPDR SERIES TRUST	XPH	$5.74M	1.87%	205,054 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$5.39M	0.13%	192,437 NS	FIGI
Royce Small-Cap Fund ROYCE FUND	—	$4.21M	0.23%	150,360 NS	FIGI
VictoryShares Small Cap Free Cash Flow ETF Victory Portfolios II	SFLO	$4.19M	0.85%	149,583 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERHRMY
FIGI_COMPOSITEBBG00WBPG4C2
FIGI_SHARE_CLASSBBG00WBPG548
CIK0001802665
ISINUS4131971040
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Harmony Biosciences is a pharmaceutical company developing treatments for rare neurological diseases.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.